Psychosocial Support Program for Caregivers of Adults Undergoing Hematopoietic Stem Cell Transplantation

What this Trial Is About

Researchers are evaluating whether a psychological support program called BMT-CARE can improve the quality of life and reduce stress for caregivers and patients undergoing hematopoietic cell transplant HCT compared to the usual care. This randomized clinical trial aims to identify what helps or hinders the use of BMT-CARE and how it affects the caregiving experience. The study is supported by the National Institutes of Health and plans to include about 400 caregivers and 400 patients. Caregivers participating in the study will be randomly assigned to either receive BMT-CARE along with usual care or to receive usual care alone. The BMT-CARE intervention is a therapist-led program consisting of six sessions that combine education about transplant care with cognitive behavioral therapy strategies aimed at improving caregiver skills and knowledge. Usual care involves meeting a transplant social worker before the transplant and additional visits as needed. The intervention lasts up to 60 days after the transplant. Participants will complete questionnaires at the start of the study and at 60, 90, and 180 days following the transplant to assess caregiver quality of life and psychosocial wellbeing. Researchers will measure outcomes using several tools including the Caregiver Oncology Quality of Life questionnaire and scales for depression, anxiety, coping, and self-efficacy. The total participation lasts up to 180 days post-transplant, during which the study team monitors the impact of the intervention on caregivers and patients.

BMT-CARE: Psychosocial Intervention for Transplant Caregivers